Berta Moritz

866 citations
22 papers · 538 · h-index 8

Impact in

Papers in

    • Cancer Treatment and Pharmacology 6
    • Colorectal Cancer Treatments and Studies 6
    • Pancreatic and Hepatic Oncology Research 3
    • Lung Cancer Treatments and Mutations 7
    • Renal cell carcinoma treatment 3

Berta Moritz

21 papers receiving 510 citations

Peers

Berta Moritz
Comparison fields: 5 of 79
  • Hematology 81
  • Internal Medicine 21
  • Oncology 156
  • Critical Care and Intensive Care Medicine 23
  • Epidemiology 130
Replace Yasushi Ozeki with:
Yasushi Ozeki Japan
Timothy J. Fischer United States
Hiromasa Harada Japan
D. Siena Italy
Ceri Hirst United Kingdom
Manuel Jesús Romero-Jiménez Spain
Ernst Eigenbauer Austria
Karan Seegobin United States
Hiroki Yuhara Japan
Antonio Bonora Italy
Berta Moritz relative to Yasushi Ozeki Japan Yasushi Ozeki's profile →
Citations per field
00.5×1.5×2.5×
Yasushi Ozeki · 1×
Citations per year

Countries citing papers authored by Berta Moritz

Since Specialization
Citations

This map shows the geographic impact of Berta Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Moritz more than expected).

Fields of papers citing papers by Berta Moritz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berta Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Moritz. The network helps show where Berta Moritz may publish in the future.

Co-authors

The 25 scholars most cited alongside Berta Moritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Berta Moritz Line = papers co-authored together Berta Moritz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003265
2 201657
3 201454
4 201248
5 201721
6 201419
7 199517
8 20137
9 20147
10
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment.
20116
11 19955
12 20144
13
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment - a study of the CESAR central european society for anticancer drug research - EWIV**
20114
14 20164
15 20024
16 20173
17 20153
18 20153
19 20153
20 20153

About Berta Moritz

Berta Moritz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Cancer Research and Internal Medicine, having authored 22 papers that have together received 538 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Genomics and Diagnostics (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Hematology (81 citations), Internal Medicine (21 citations), Oncology (156 citations), Critical Care and Intensive Care Medicine (23 citations) and Epidemiology (130 citations). Berta Moritz has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Ester D. de Kleijn, Werner Engl, Jan A. Hazelzet, C. Erik Hack, Koen F. M. Joosten, Ronald de Groot, Paul Mulder, Ulrich Jaehde, Stefanie Kraff and Jan H.M. Schellens. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Clinical Pharmacokinetics, British Journal of Haematology and CPT Pharmacometrics & Systems Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact